Acumen Pharmaceuticals (ABOS) Stock Price

$1.14 0%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    4
  • Fundamental

    1
  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Acumen Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

ABOS AI Stock Analysis

AI stock analysis for ABOS is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Acumen Pharmaceuticals (ABOS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Acumen Pharmaceuticals (ABOS) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Acumen Pharmaceuticals (ABOS), currently trading at $1.14, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ABOS

LSE
  • Acumen Pharmaceuticals, Inc.

  • Symbol

    ABOS

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    69.1M

Similar Stocks

ABOS Alternative Data

Web Traffic

Acumen Pharmaceuticals receives an estimated 4516 monthly visitors to acumenpharm.com.

  • Web Traffic

    4516

  • Change from Previous Month

    19.5%

  • 3 Month Change

    7.6%

  • YoY Change

    7.6%

Twitter Followers

Acumen Pharmaceuticals has 269 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.5% over the last month.

  • Twitter Followers

    269

  • Daily Change

    0%

  • 1 Month Change

    1.5%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Facebook Engagement

Acumen Pharmaceuticals has engaged 21 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    21

  • Daily Change

    4.5%

  • 1 Month Change

    600%

  • 3 Month Change

    600%

  • YoY Change

    600%

Instagram Followers

Acumen Pharmaceuticals has 115 Instagram Followers on its main Instagram account, up by 0.9% over the last month.

  • Instagram Followers

    115

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    0.9%

  • YoY Change

    0.9%

LinkedIn Followers

5,868 are following Acumen Pharmaceuticals on LinkedIn, up by 1.2% over the last month.

  • LinkedIn Followers

    5868

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    6.1%

Job Postings

Acumen Pharmaceuticals has an estimated 0 open job postings, which is down -100% over the last month.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

  • YoY Change

    100%

LinkedIn Employees

According to LinkedIn, Acumen Pharmaceuticals has 67 employees.

  • LinkedIn Employees

    67

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    6.9%

  • YoY Change

    6.9%

Reddit Mentions

Acumen Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Acumen Pharmaceuticals was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

ABOS Financials

ABOS Key Metrics
  • Total Revenue

    $0

  • Net Income

    -$29.8M

  • Earnings per Share

    -$0.5

  • Free cash flow

    -$24.6M

  • EBITDA

    -$28.7M

  • EBITDA Ratio

    0

  • Total Assets

    $239M

ABOS 2-year Revenue & Income
ABOS 2-year Free Cash Flow

ABOS Technicals

ABOS SMA
ABOS RSI

FAQ

What's the current price of Acumen Pharmaceuticals (ABOS) Stock?
The price of an Acumen Pharmaceuticals (ABOS) share is $1.14.

What's the market cap of Acumen Pharmaceuticals?
The current market cap of Acumen Pharmaceuticals is 69.1M.

Should I buy or sell ABOS?
Acumen Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Acumen Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Acumen Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Acumen Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Acumen Pharmaceuticals (ABOS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Acumen Pharmaceuticals stock right now, as the outlook appears bearish.

What are some stocks similar to Acumen Pharmaceuticals (ABOS) that investors often compare it to?
Acumen Pharmaceuticals (ABOS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Acumen Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Acumen Pharmaceuticals' stock price to be around $1.06 in 2026. Starting from the current price of $1.14, this represents a 7.4% change in price, indicating a bearish outlook for the stock.

How to buy Acumen Pharmaceuticals (ABOS) Stock?
Acumen Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Acumen Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.